top of page

SUBSCRIBE TO OUR NEWSLETTER

THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

Search

With the industry facing increasing pressure to deliver faster, smarter, and more efficient clinical trials, MEDSIR enters SCOPE with a clear message: ‘Upgrading your pipeline. Faster.’ In this internal interview, Laura Calabuig, Business Development Director, shares MEDSIR’s perspective on why this moment matters, how the company’s unique model addresses real‑world development challenges

With the industry facing increasing pressure to deliver faster, smarter, and more efficient clinical trials, MEDSIR enters SCOPE with a clear message: ‘Upgrading your pipeline. Faster.’ In this internal interview, Laura Calabuig, Business Development Director, shares MEDSIR’s perspective on why this moment matters, how the company’s unique model addresses real‑world development challenges

“True agility starts with designing the right clinical trial from the beginning”

Feb 24 min read

bottom of page